Tove Rylander‐Rudqvist

Author

Karolinska Institutet

Also Known As

T Rylander-Rudqvist, T. Rylander-Rudqvist, Tove Rylander-Rudqvist, Tove Rylander‐Rudqvist

Publications

750

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Tokyo Metropolitan Komagome Hospital University of Helsinki Medical Products Agency Institute of Genetics

About

Tove Rylander‐Rudqvist is an author at Karolinska Institutet specializing in cancer epidemiology, cancer risk factors, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	181
2	Public Health	2	2	181
3	Endocrinology	1	1	69
4	Epidemiology	1	1	112
5	Nutrition	1	1	69

Tove Rylander‐Rudqvist

Publications

666

Citations

H-Index

Page 1

	Year	Citations
Quality and Quantity of Saliva DNA Obtained from the Self-administrated Oragene Method—A Pilot Study on the Cohort of Swedish Men Tove Rylander‐Rudqvist, Niclas Håkansson, Gunnel Tybring, Cancer Epidemiology Biomarkers & Prevention	2006	168
Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort Study Reiko Suzuki, Weimin Ye, Tove Rylander‐Rudqvist, JNCI Journal of the National Cancer Institute	2005	137
Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study Reiko Suzuki, Tove Rylander‐Rudqvist, Weimin Ye, International Journal of Cancer Breast OncologySwedish WomenEstrogen ReceptorEpidemiology Of CancerCancer Risk Factors	2006	112
Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk Tove Rylander‐Rudqvist Carcinogenesis	2003	84
Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status—A prospective cohort study among Swedish women Reiko Suzuki, Tove Rylander‐Rudqvist, Weimin Ye, International Journal of Cancer NutritionBreast OncologyNutritional EpidemiologyDietary Fiber IntakeProgesterone Receptor	2007	69
Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women Reiko Suzuki, Tove Rylander‐Rudqvist, Shigehira Saji, British Journal of Cancer	2008	41
Cytochrome P450 1B1 Gene Polymorphisms and Postmenopausal Endometrial Cancer Risk Tove Rylander‐Rudqvist, Sara Wedrén, Gudrun Jonasdottir, Cancer Epidemiology Biomarkers & Prevention	2004	32
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study Kristjana Einarsdóttir, Tove Rylander‐Rudqvist, Keith Humphreys, Breast Cancer Research	2005	23

Page 1